PeptideMeter result on a Guangzhou semaglutide lot lands 1.0 points below the supplier’s figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 10 of 10 of this archive, newest first.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
The supplier has not disputed the finding. It has not explained the gap either.
We submitted vials for endotoxin determination and report the results, the method and the laboratory, because a pyrogen figure without a method is as empty as a purity…
The result is unremarkable. What the report omits is not.
The header identifies the batch, the table records the tests, and the footer says who is answerable. Two of the three are usually incomplete.
A brief and unromantic tour of the interface between a liquid sample and a vacuum.
A reminder that a purity figure is the output of a method, and that methods differ.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
What would make a difference is not a regulator. It is three lines on a certificate, all of which are already known to whoever wrote it.
The supplier has not disputed the finding. It has not explained the gap either.
A reminder that a purity figure is the output of a method, and that methods differ.